Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Atypical Antipsychotic [EPC]
Clozapine is a potent atypical antipsychotic medication primarily indicated for treatment-resistant schizophrenia. Due to risks of severe neutropenia, it is managed through a restricted REMS program.
Name
Clozapine
Raw Name
CLOZAPINE
Category
Atypical Antipsychotic [EPC]
Drug Count
3
Variant Count
42
Last Verified
February 17, 2026
RxCUI
197535, 197536, 309374, 429212, 476177, 476179, 721773, 996921, 1006801, 104775, 104776, 1369825, 1369831
UNII
J60AR2IKIC
About Clozapine
Clozapine is a potent atypical antipsychotic medication primarily indicated for treatment-resistant schizophrenia. Due to risks of severe neutropenia, it is managed through a restricted REMS program.
Detailed information about Clozapine
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Clozapine.
Clozapine is unique because it is the only medication proven to be effective for treatment-resistant schizophrenia, defined as a lack of response to at least two different antipsychotic trials of adequate dose and duration. Furthermore, it is the only FDA-approved medication specifically indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Despite its high efficacy, Clozapine is typically reserved as a third-line treatment because of its potential for serious adverse effects, most notably agranulocytosis (a dangerous drop in white blood cell count), which requires mandatory blood monitoring through the Clozapine REMS (Risk Evaluation and Mitigation Strategy) program.
The exact mechanism of action of Clozapine is complex and not fully understood, but it differs significantly from other antipsychotics. While most antipsychotics primarily block dopamine D2 receptors in the brain, Clozapine has a relatively weak affinity for D2 receptors. Instead, it acts as an antagonist at a wide array of neurotransmitter receptors. It shows high affinity for dopamine D4 receptors and serotonin 5-HT2A receptors. The blockade of 5-HT2A receptors is thought to contribute to its efficacy against the 'negative' symptoms of schizophrenia (such as social withdrawal and lack of emotion) and its low propensity for causing movement disorders.
At the molecular level, Clozapine also interacts with:
Clozapine is FDA-approved for the following indications:
Off-label uses (uses not approved by the FDA but sometimes prescribed by doctors) include:
Clozapine is available in several oral formulations to accommodate different patient needs:
> Important: Only your healthcare provider can determine if Clozapine is right for your specific condition. Because of the risk of agranulocytosis, Clozapine is only available through a restricted program called the Clozapine REMS.
Dosage of Clozapine must be highly individualized and titrated slowly to minimize the risk of side effects such as hypotension (low blood pressure), seizures, and sedation.
Clozapine is not FDA-approved for use in pediatric patients (children and adolescents under 18 years of age). Safety and effectiveness have not been established in this population. If a specialist chooses to use it off-label for a child, it is done with extreme caution and very low starting doses.
Patients with significant kidney disease may require lower doses and more frequent monitoring. Clozapine is not significantly cleared by hemodialysis, so supplementary doses after dialysis are not necessary.
Clozapine is extensively metabolized by the liver. Patients with liver impairment should start with lower doses and be monitored closely for signs of toxicity. If hepatitis or jaundice develops, the medication should be discontinued.
Patients aged 65 and older are more sensitive to the side effects of Clozapine, particularly orthostatic hypotension and anticholinergic effects (like urinary retention and constipation). Healthcare providers typically start elderly patients at 12.5 mg once daily and titrate much more slowly than in younger adults.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up.
CRITICAL: If you stop taking Clozapine for more than 48 hours (2 days), you must NOT restart your usual dose. You must contact your healthcare provider immediately, as the medication must be restarted at the lowest dose (12.5 mg) and re-titrated to prevent severe side effects like seizures or cardiac arrest.
An overdose of Clozapine is a medical emergency. Symptoms may include:
In the event of a suspected overdose, call 911 or your local emergency services immediately. Emergency treatment often involves gastric lavage (stomach pumping) if performed early, administration of activated charcoal, and intensive supportive care in a hospital setting.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without direct medical guidance, as this can lead to a relapse of symptoms or severe withdrawal effects.
Clozapine is associated with a high frequency of side effects, many of which occur during the initial titration phase. Common effects include:
> Warning: Stop taking Clozapine and call your doctor immediately if you experience any of these serious symptoms:
The FDA has issued five distinct Black Box Warnings for Clozapine, the highest level of safety warning:
Report any unusual symptoms to your healthcare provider immediately. Early detection of side effects is critical for safe Clozapine therapy.
Clozapine is a high-alert medication that requires close collaboration between the patient, the doctor, and the pharmacist. Because of its complex safety profile, it is only prescribed when other medications have failed. Patients must be willing to undergo regular blood monitoring and report any physical changes immediately.
According to the FDA-approved labeling, Clozapine carries five major boxed warnings:
Clozapine causes significant sedation and can impair judgment and motor skills. Patients should not drive, operate heavy machinery, or engage in dangerous activities until they are certain the medication does not affect them adversely. This is especially important during the first few weeks of treatment or after a dose increase.
Alcohol should be strictly avoided. Clozapine and alcohol both depress the central nervous system. Combining them can lead to extreme drowsiness, respiratory depression, and an increased risk of accidents or overdose.
Stopping Clozapine abruptly is dangerous. It can lead to 'cholinergic rebound' (symptoms like sweating, nausea, and vomiting) and a rapid return of psychotic symptoms. If the drug must be stopped, it should be tapered gradually over 1 to 2 weeks under medical supervision. If it is stopped for a medical emergency (like low white blood cells), the patient must be monitored closely for withdrawal and relapse.
> Important: Discuss all your medical conditions, especially heart, lung, or kidney problems, with your healthcare provider before starting Clozapine.
Clozapine does not typically interfere with standard urine drug screens. However, it can cause false elevations in certain blood tests, such as:
For each interaction, the management strategy usually involves either avoiding the combination, adjusting the Clozapine dose based on blood level monitoring (therapeutic drug monitoring), or increasing the frequency of side effect assessments.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines and sleep aids.
Clozapine must NEVER be used in the following circumstances:
In these cases, the healthcare provider will perform a careful risk-benefit analysis:
There is no significant evidence of cross-sensitivity between Clozapine and other classes of antipsychotics (like phenothiazines). However, patients who have had severe skin reactions to other tricyclic medications should be monitored closely.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of blood disorders or heart problems, before prescribing Clozapine.
Clozapine is classified as Pregnancy Category B (under the old FDA system). This means animal studies have not shown a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Clozapine is excreted in human breast milk. Because of the potential for serious adverse reactions in nursing infants—specifically the risk of agranulocytosis and sedation—breastfeeding is not recommended while taking Clozapine. Mothers must choose between breastfeeding and taking this medication.
Clozapine is not approved for use in patients under 18 years old. In adolescents, the risk of side effects like weight gain and metabolic changes is significantly higher than in adults. If used off-label by a specialist, monitoring must be exceptionally rigorous.
Elderly patients (65+) are at a significantly higher risk for:
Clozapine is not removed by the kidneys in its unchanged form, but its metabolites are. In patients with severe renal impairment (CrCl < 30 mL/min), dosing should be cautious. There is no specific GFR-based formula for Clozapine, but clinical monitoring for toxicity is essential.
Patients with stable chronic liver disease can take Clozapine, but they require lower starting doses and slower titration. In patients with active, progressive liver disease or liver failure, Clozapine is generally avoided. If a patient develops jaundice (yellowing of the skin) while on Clozapine, the drug should be stopped immediately.
> Important: Special populations require individualized medical assessment and more frequent clinical monitoring to ensure safety.
Clozapine is a 'broad-spectrum' antipsychotic. Its primary therapeutic effects in schizophrenia are thought to stem from its unique binding profile. Unlike typical antipsychotics that bind tightly to dopamine D2 receptors in the mesolimbic and nigrostriatal pathways, Clozapine has a low affinity for D2 receptors and a high affinity for serotonin 5-HT2A receptors. This 'loose' binding to D2 receptors is hypothesized to provide antipsychotic effects without the high risk of movement disorders (EPS). Additionally, it acts as an antagonist at D1, D4, alpha-1 adrenergic, H1 histaminergic, and various muscarinic receptors.
The onset of action for Clozapine's sedative effects is rapid (within hours), but its full antipsychotic effect usually takes 4 to 12 weeks to manifest. Unlike many other drugs, there is a clear dose-response relationship, but individual blood levels vary widely. Therapeutic drug monitoring (TDM) is often used, with a target plasma level typically between 350 ng/mL and 600 ng/mL for optimal response.
| Parameter | Value |
|---|---|
| Bioavailability | 27% - 50% (due to first-pass metabolism) |
| Protein Binding | 97% (primarily to albumin) |
| Half-life | ~12 hours (range 8-16 hours) |
| Tmax | 1.5 - 2.5 hours |
| Metabolism | Hepatic (Primary: CYP1A2; Secondary: CYP3A4) |
| Excretion | Renal (50%), Fecal (30%) |
Clozapine is the prototypical Atypical Antipsychotic [EPC]. It paved the way for other medications in this class, such as risperidone, olanzapine, and quetiapine. However, Clozapine remains unique in its efficacy for treatment-resistant cases and its specific risk profile.
Common questions about Clozapine
Clozapine is primarily used for the treatment of severe schizophrenia in patients who have not responded to at least two other antipsychotic medications. This is known as treatment-resistant schizophrenia, and Clozapine is often considered the most effective option for these difficult-to-treat cases. Additionally, it is the only FDA-approved medication proven to reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Because of its potential for serious side effects, it is generally reserved for patients who have not found success with other treatments. It is also occasionally used off-label for severe psychosis associated with Parkinson's disease or refractory bipolar disorder.
The most common side effects of Clozapine include extreme drowsiness (sedation), excessive salivation (drooling), especially at night, and a rapid heart rate (tachycardia). Many patients also experience significant weight gain, dizziness when standing up (orthostatic hypotension), and constipation. Constipation is a particularly important side effect to monitor, as it can become severe or life-threatening if not managed with diet or laxatives. Some patients may also experience a mild fever during the first few weeks of treatment. While many of these side effects improve over time, some may require additional medications or dosage adjustments by your doctor.
No, you should strictly avoid drinking alcohol while taking Clozapine. Both alcohol and Clozapine are central nervous system depressants, meaning they slow down brain activity. Combining them can lead to dangerous levels of sedation, impaired coordination, and a significantly increased risk of respiratory depression (dangerously slow breathing). Furthermore, alcohol can worsen the dizziness and low blood pressure caused by Clozapine, increasing the risk of fainting and falls. For your safety, it is essential to abstain from alcohol entirely during your treatment.
Clozapine should only be used during pregnancy if the potential benefits to the mother outweigh the potential risks to the developing fetus. While animal studies have not shown direct harm, there is limited data on human pregnancies. Babies born to mothers who take Clozapine during the third trimester may experience withdrawal symptoms or movement disorders after birth, such as tremors, agitation, or difficulty breathing. However, stopping Clozapine during pregnancy can lead to a severe relapse of schizophrenia, which also poses risks to both mother and baby. If you are pregnant or planning to become pregnant, you must have a detailed discussion with your psychiatrist and obstetrician.
While some effects like improved sleep and reduced agitation may be noticed within the first few days, the full antipsychotic benefits of Clozapine usually take longer to develop. Most patients begin to see a significant reduction in hallucinations and delusions within 4 to 8 weeks of reaching an effective dose. In some cases, it may take up to 3 to 6 months of consistent treatment to see the maximum benefit. Because the dose must be increased very slowly at the beginning to ensure safety, patience is required during the initial titration phase. Your doctor will monitor your progress closely to determine the best maintenance dose for you.
No, you should never stop taking Clozapine suddenly unless specifically instructed by your doctor during a medical emergency. Abruptly stopping the medication can cause a rapid and severe return of psychotic symptoms, often worse than before. It can also lead to 'cholinergic rebound' symptoms, such as severe nausea, vomiting, sweating, and diarrhea. If Clozapine needs to be discontinued, it must be tapered slowly over at least one to two weeks. If you miss your dose for more than two days, you must contact your doctor immediately, as you cannot restart at your usual dose and must begin the titration process again from the start.
If you miss a single dose of Clozapine, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular schedule; do not double the dose. However, if you miss your medication for more than 48 hours (two full days), you must call your doctor before taking another dose. This is critical because your body loses its tolerance to the side effects very quickly. Re-starting your usual dose after a two-day break can lead to dangerous side effects like seizures, severe low blood pressure, or heart collapse. Your doctor will provide instructions on how to safely restart the medication at a low dose.
Yes, weight gain is a very common and often significant side effect of Clozapine. It is considered one of the antipsychotics with the highest risk for weight gain and metabolic changes. This occurs because the medication increases appetite and can change how your body processes sugars and fats. Significant weight gain can increase the risk of developing type 2 diabetes and heart disease. To manage this, it is important to monitor your weight regularly and work with your healthcare team on a healthy diet and exercise plan. Your doctor will also perform regular blood tests to check your blood sugar and cholesterol levels.
Clozapine has many potential interactions with other medications, some of which are very serious. You must inform your doctor about every medication you take, including over-the-counter drugs and herbal supplements. It should not be taken with drugs that also suppress bone marrow (like carbamazepine) or with certain antidepressants like fluvoxamine, which can dangerously increase Clozapine levels. Other medications for blood pressure, sleep, or allergies can also interact by increasing sedation or causing heart rhythm problems. Your pharmacist and doctor will check for these interactions before starting your treatment to ensure your regimen is safe.
Yes, Clozapine is available as a generic medication in several forms, including oral tablets and orally disintegrating tablets. The generic versions are bioequivalent to the brand-name versions (like Clozaril) and are generally more cost-effective. Regardless of whether you take the brand-name or generic version, the safety requirements remain the same. All patients taking any form of Clozapine must be enrolled in the Clozapine REMS program and undergo the mandatory blood monitoring for white blood cell counts. Your pharmacy will ensure that your blood work is up to date before dispensing either the brand or the generic medication.